2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Obesity Induced IL-18 Production Impairs FOXP3+ Treg Function and Increases Risk of Primary Graft Dysfunction in Lung Transplant Recipients

W. W. Hancock¹, T. Zhang¹, U. H. Beier¹, A. Samanta¹, R. Han¹, L. Wang¹, J. Jiao¹, J. M. Diamond², D. S. Wilkes³, D. J. Lederer⁴, R. A. Simmons², J. D. Christie², T. Akimova²
Occult Liver Graft Fibrosis Prior to Transplantation Influences Clinical Outcomes

H. Hirao, T. Ito, K. Kadono, S. Kageyama, K. Nakamura, K. J. Dery, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski
One Organ Procurement Organization’s Uncontrolled Donation After Cardiocirculatory Death Program Increases The Donor Pool And Results In The Transplantation Of 254 Organs

R. D. Hasz, S. M. West, H. M. Nathan
One Study: A Consortium Model of Clinical Trials Optimized for Comparing New Immune Therapies via Centralized Immune Monitoring

B. Sawitzki¹, S. Schlickeiser¹, M. Streitz¹, K. Jürchott¹, J. Hutchinson², E. Geissler², P. Investigators³
Opening the Doors of Hope: HIV-Positive Living Kidney Donation

S. Rusch, L. Fieldman, M. Hemmersbach-Miller, C. R. Wolfe
Opioid and Benzodiazepine Use in Lung Transplant Candidates: A National Survey of Policies and Practices

H. Bruschwein¹, V. Andersen¹, H. Patel², J. Fleming³, A. Shahane¹, M. Weder¹
Opioid Minimization in Kidney Transplant: Achievable Quicker Than You Think

J. N. Fleming, N. Patel, H. Gonzales, N. A. Pilch, S. Parks, C. Perez, P. K. Baliga, S. N. Nadig, D. J. Taber, V. Rohan
Opioid Use Policies and Practices in Liver Transplant and Lung Transplant Candidates: A Comparison of National Surveys

H. Bruschwein¹, V. Andersen¹, H. Patel², S. S. Rogal³, J. N. Fleming⁴
OPO Aggressiveness Index: A Novel OPO Performance Metric That Incentivizes Pursuit of Marginal Deceased Donor Candidates

L. Liyanage, Y. Yu, K. Jackson, J. Garonzik-Wang, D. Segev, A. Massie
Optimal Timing of Hepatitis C Treatment among HIV/HCV Co-Infected End-Stage Renal Disease Patients: Pre vs. Post-Transplant

B. Shelton¹, G. Berdahl¹, D. Sawinski², B. Linas³, P. Reese², M. Mustian¹, R. Reed¹, P. MacLennan¹, J. Locke¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z